BruggerUHorisbergerBRuckstuhlA. Health technology assessment in Switzerland: a descriptive analysis of “Coverage with Evidence Development” decisions from 1996 to 2013. BMJ Open2015; 5: e007021–e007021.
2.
SmeethL. We still need observational studies of drugs – they just need to be better. Int J Epidemiol2006; 35: 1310–1311.
3.
WestabyS. Comparison of hospital episode statistics and central cardiac audit database in public reporting of congenital heart surgery mortality. BMJ2007; 335: 759–759.
4.
Rawlins M. Harveian oration: DE TESTIMONIO on the evidence for decisions about the use of therapeutic interventions. Speech presented at The Royal College of Physicians, London, 16 October 2008.
5.
Hill B. Heberden Oration: reflections on the controlled trial. Speech presented at The Royal College of Physicians, London, 1965.
6.
PatrickHGallaugherSCzoski-MurrayC. Usefulness of a short-term register for health technology assessment where the evidence base is poor. Int J Technol Assess Health Care2010; 26: 95–101.
7.
LyratzopoulosGPatrickHCampbellB. Registers needed for new interventional procedures. Lancet2008; 371: 1734–1736.
8.
DreyerNGarnerS. Registers for robust evidence. JAMA2009; 302: 790–791.
9.
GrilliRTaroniF. Managing the introduction of expensive medical procedures: use of a registry. J Health Serv Res Policy2006; 11: 89–93.
10.
BlackN. Why we need observational studies to evaluate the effectiveness of health care. BMJ1996; 312: 1215–1215.
11.
BarkunJS. Evaluation and stages of surgical innovations. Lancet2009; 374: 1089–1096.
12.
von ElmEAltmanDGEggerM. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol2008; 61: 344–349.
13.
CarlsonGLPatrickHAminAI. Management of the open abdomen: a national study of clinical outcome and safety of negative pressure wound therapy. Ann Surg2013; 257: 1154–1159.
